Founded in 2019 by physicians Ginger and Jay Constantine, PleoPharma develops pharmaceutical treatments for substance use disorders, beginning with an investigational oral therapy for cannabis withdrawal. The Phoenixville-based company emerged after the founders saw patients struggling to stop cannabis use and discovered that no effective treatment existed; its lead program, PP-01, has completed Phase 2.